AI
ATRC icon

Atom Investors’s AtriCure ATRC Stock Holding History

Atom Investors’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-62,095
Closed -$1.74M – 498
2024
Q3 		$1.74M Buy
+62,095
New +$1.53M 0.18% 174
2019
Q1 		– Sell
-27,470
Closed -$841K – 514
2018
Q4 		$841K Buy
+27,470
New +$856K 0.08% 367

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Atom Investors's ATRC Position: Q4 2024 in Review

Atom Investors sold out of AtriCure (ATRC) in Q4 2024, closing a stake of 62,095 shares — an estimated $1.74M sold.

Atom Investors first reported a position in ATRC in Q4 2018 and held it in 2 quarters. The position peaked at $1.74M in Q3 2024. 213 funds tracked by Wall St. Rank hold ATRC as of Q4 2024.

  • Atom Investors reported no remaining AtriCure position as of Q4 2024 after selling out during the quarter.
  • Atom Investors sold 62,095 AtriCure shares in Q4 2024, an estimated $1.74M.
  • Atom Investors first reported a position in AtriCure in Q4 2018 and held it in 2 quarters.
  • Atom Investors's AtriCure position peaked at $1.74M in Q3 2024.
  • 213 funds tracked by Wall St. Rank held AtriCure as of Q4 2024.

Based on Atom Investors's 13F filing for Q4 2024, filed 14 Feb 2025.